T1	PROC 46 91	Evaluación de la seguridad y la tolerabilidad
T2	PROC 96 115	recambio plasmático
#1	AnnotatorNotes T2	C0032113; Plasma Exchange; Therapeutic or Preventive Procedure
T3	LIVB 119 128	pacientes
#2	AnnotatorNotes T3	C0030705; Patients; Patient or Disabled Group
T4	DISO 133 155	síndrome post-COVID-19
T5	DISO 157 160	SPC
T6	PROC 181 209	recambio plasmático simulado
T7	LIVB 211 218	placebo
T8	PROC 243 262	Recambio plasmático
#3	AnnotatorNotes T8	C0032113; Plasma Exchange; Therapeutic or Preventive Procedure
T9	PROC 268 279	tratamiento
#4	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	LIVB 285 294	pacientes
#5	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 299 321	Síndrome post-COVID-19
T12	Date 312 321	-COVID-19
T13	PROC 323 364	Estudio piloto aleatorizado y doble ciego
T14	DISO 388 393	Covid
T15	DISO 407 429	Síndrome post-COVID-19
T16	Date 420 427	-COVID-
T17	DISO 456 478	Síndrome post-COVID-19
T18	Date 469 476	-COVID-
T19	LIVB 508 541	Individuos masculinos o femeninos
T20	Age 545 558	18 años o más
T21	DISO 576 607	infección previa por SARS-CoV-2
T22	Duration 608 624	al menos 90 días
T23	PROC 661 691	prueba SARS-CoV-2 nasofaríngea
T24	PROC 693 718	Polymerase chain reaction
T25	PROC 720 723	PCR
#6	AnnotatorNotes T25	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique | C0201657; C-reactive protein measurement; Laboratory Procedure
T26	PROC 777 810	test de antígenos rápido COVID-19
T27	PROC 812 815	TAR
#7	AnnotatorNotes T27	C1963724; Antiretroviral therapy; Therapeutic or Preventive Procedure
T28	PROC 824 847	serología de SARS-CoV-2
T29	PROC 860 891	vacunación contra el SARS-CoV-2
#8	AnnotatorNotes T29	C5203672; SARS-CoV-2 vaccination; Therapeutic or Preventive Procedure
T30	PROC 898 934	Serología SARS-CoV-2 antiproteína N.
T31	DISO 939 954	Síntomas de SPC
T32	Duration 966 973	90 días
T33	DISO 980 989	infección
#9	AnnotatorNotes T33	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T34	Duration 1002 1018	al menos 2 meses
T35	Neg_cue 1021 1023	no
T36	Negated 1024 1045	pueden explicarse con
T37	PROC 1049 1072	diagnóstico alternativo
T38	Negated 1049 1060	diagnóstico
T39	Neg_cue 1077 1079	No
T40	Negated 1080 1125	puede realizar todas las tareas / actividades
T41	DISO 1146 1154	síntomas
#10	AnnotatorNotes T41	C1457887; Symptoms; Sign or Symptom
T42	DISO 1160 1165	dolor
#11	AnnotatorNotes T42	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T43	DISO 1167 1176	depresión
#12	AnnotatorNotes T43	C0011570; Mental Depression; Mental or Behavioral Dysfunction | C0011581; Depressive disorder; Mental or Behavioral Dysfunction | C0344315; Depressed mood; Mental or Behavioral Dysfunction
T44	DISO 1179 1187	ansiedad
#13	AnnotatorNotes T44	C0003467; Anxiety; Mental or Behavioral Dysfunction
T45	PROC 1223 1249	escala de estado funcional
T46	LIVB 1253 1262	pacientes
#14	AnnotatorNotes T46	C0030705; Patients; Patient or Disabled Group
T47	Date 1263 1274	post-COVID-
T48	PROC 1318 1348	canalización venosa periférica
T49	LIVB 1356 1378	mujeres en edad fértil
T50	Age 1367 1378	edad fértil
T51	PROC 1416 1437	método anticonceptivo
#15	AnnotatorNotes T51	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T52	CHEM 1469 1495	anticonceptivos hormonales
T53	DEVI 1497 1521	dispositivo intrauterino
#16	AnnotatorNotes T53	C0021900; Intrauterine Devices; Medical Device
T54	DEVI 1523 1526	DIU
#17	AnnotatorNotes T54	C0021900; Intrauterine Devices; Medical Device
T55	DISO 1531 1552	esterilidad anatómica
T56	PROC 1617 1626	protocolo
#18	AnnotatorNotes T56	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T57	PROC 1645 1656	seguimiento
#19	AnnotatorNotes T57	C0420316; Other follow-up; Health Care Activity
T58	PHYS 1702 1713	Comprensión
#20	AnnotatorNotes T58	C0162340; Comprehension; Mental Process
T59	PROC 1738 1762	consentimiento informado
#21	AnnotatorNotes T59	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T60	DISO 1793 1817	Infección por SARS-CoV-2
#22	AnnotatorNotes T60	C5203670; COVID19 (disease); Disease or Syndrome
T61	PROC 1818 1831	diagnosticada
#23	AnnotatorNotes T61	C0011900; Diagnosis; Diagnostic Procedure
T62	Duration 1840 1862	los 90 días anteriores
T63	CHEM 1883 1910	vacuna contra el SARS-CoV-2
T64	Duration 1919 1941	los 30 días anteriores
T65	Neg_cue 1946 1948	No
T66	Negated 1953 1965	limitaciones
T67	LIVB 2001 2007	sujeto
#24	AnnotatorNotes T67	C0681850; Study Subject; Group
T68	PROC 2097 2113	escala funcional
T69	Dose 2157 2163	250 ml
T70	Route 2175 2186	intravenoso
T71	DISO 2223 2259	insuficiencia cardíaca descompensada
T72	DISO 2262 2281	insuficiencia renal
#25	AnnotatorNotes T72	C0035078; Kidney Failure; Disease or Syndrome | C1565489; Renal Insufficiency; Disease or Syndrome
T73	DISO 2297 2308	de líquidos
T74	LIVB 2327 2372	Mujeres embarazadas o en periodo de lactancia
T75	PROC 2404 2429	plasmaféresis terapéutica
T76	Contraindicated 2404 2429	plasmaféresis terapéutica
T77	Neg_cue 2431 2433	No
T78	DEVI 2455 2480	catéter venoso periférico
#26	AnnotatorNotes T78	C2985513; Peripheral Venous Catheter; Medical Device
T79	Negated 2455 2480	catéter venoso periférico
T80	DISO 2491 2517	inestabilidad hemodinámica
T81	DISO 2520 2530	septicemia
#27	AnnotatorNotes T81	C0036690; Septicemia; Disease or Syndrome | C0243026; Sepsis; Disease or Syndrome
T82	DISO 2532 2539	alergia
#28	AnnotatorNotes T82	C0020517; Hypersensitivity; Pathologic Function
T83	CHEM 2552 2575	plasma fresco congelado
T84	CHEM 2578 2585	coloide
#29	AnnotatorNotes T84	C0009361; Colloids; Biomedical or Dental Material
T85	CHEM 2588 2596	albúmina
#30	AnnotatorNotes T85	C0001924; Albumins; Amino Acid, Peptide, or Protein · Biologically Active Substance
T86	DISO 2611 2618	alergia
#31	AnnotatorNotes T86	C0020517; Hypersensitivity; Pathologic Function
T87	CHEM 2633 2641	heparina
#32	AnnotatorNotes T87	C0019134; heparin; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T88	PROC 2646 2668	Ingresos hospitalarios
#33	AnnotatorNotes T88	C0184666; Hospital admission; Health Care Activity
T89	Date 2669 2677	actuales
T90	PROC 2721 2732	seguimiento
#34	AnnotatorNotes T90	C0420316; Other follow-up; Health Care Activity
T91	Neg_cue 2749 2765	Incapacidad para
T92	PROC 2776 2800	consentimiento informado
#35	AnnotatorNotes T92	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T93	Negated 2776 2800	consentimiento informado
T94	Negated 2807 2833	cumplir con los requisitos
T95	LIVB 2864 2876	investigador
#36	AnnotatorNotes T95	C0035173; Research Personnel; Professional or Occupational Group
T96	Date 2895 2901	actual
T97	PROC 2950 2964	ensayo clínico
#37	AnnotatorNotes T97	C0008976; Clinical Trials; Research Activity
T98	Date 2971 2980	el día 90
T99	PROC 2984 2995	seguimiento
#38	AnnotatorNotes T99	C0420316; Other follow-up; Health Care Activity
